Asia-Pacific Working Group consensus on non-variceal upper gastrointestinal bleeding

Gut

Volumn 60, Issue 9, 2011, Pages 1170-1177

  Sung, Joseph J Y ^a   Chan, Francis K L ^b   Chen, Minhu ^c   Ching, Jessica Y L ^c   Ho, K Y ^d   Kachintorn, Udom ^c   Kim, Nayoung ^e   Lau, James Y W ^c   Menon, Jayaram ^c   Rani, Abdul Aziz ^c   Reddy, Nageshwar ^c   Sollano, Jose ^f   Sugano, Kentaro ^g   Tsoi, Kelvin K F ^b   Wu, Chun Ying ^c   Yeomans, Neville ^c   Vakil, Namish ^h   Goh, K L ^c  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b Department of Medicine and Therapeutics   (Hong Kong)

^c Asia Pacific Working Group   (China)

^d NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^e Asia Pacific Working Group   (South Korea)

^f Asia Pacific Working Group   (Philippines)

^g Asia Pacific Working Group   (Japan)

^h Aurora Medical Center Summit   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; CLOPIDOGREL; DICLOFENAC; ESOMEPRAZOLE; LANSOPRAZOLE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PROTON PUMP INHIBITOR;

ACUTE CORONARY SYNDROME; ADJUVANT THERAPY; ANGIOGRAPHY; ARTHRITIS; ARTIFICIAL EMBOLISM; ASIA; BLATCHFORD SCORE; BLOOD CLOT; COMORBIDITY; CONSENSUS; DOSE RESPONSE; DRUG ANTAGONISM; DRUG DOSE COMPARISON; DRUG DOSE REGIMEN; DRUG MEGADOSE; EARLY INTERVENTION; ENDOSCOPIC THERAPY; GASTROINTESTINAL ENDOSCOPY; HEMOSTASIS; HOSPITAL DISCHARGE; HUMAN; LOW DRUG DOSE; PATIENT SELECTION; PEPTIC ULCER BLEEDING; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SCORING SYSTEM; TREATMENT INDICATION; UPPER GASTROINTESTINAL BLEEDING;

ASPIRIN; DRUG THERAPY, COMBINATION; EMBOLIZATION, THERAPEUTIC; ENDOSCOPY, GASTROINTESTINAL; EVIDENCE-BASED MEDICINE; GASTROINTESTINAL HEMORRHAGE; HUMANS; PATIENT SELECTION; PLATELET AGGREGATION INHIBITORS; PROGNOSIS; PROTON PUMP INHIBITORS; TIME FACTORS;

EID: 80051545117     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2010.230292     Document Type: Review

References (70)

1. Barkun A, Bardou M, Kuipers EJ, et al. International consensus recommendations on the management of patients with non-variceal upper gastrointestinal bleeding (ICON-UGIB). Ann Intern Med 2010;152:101-13.
2. Rockall TA, Logan RF, Devlin HB, et al. Risk assessment after acute upper gastrointestinal haemorrhage. Gut 1996;38:316-21. (Pubitemid 26074312)
3. Blatchford O, Murray WR, Blatchford M. A risk score to predict need for treatment for upper-gastrointestinal haemorrhage. Lancet 2000;356:1318-21.
4. Pang SH, Ching JY, Lau JY, et al. Comparing the Blatchford and pre-endoscopic Rockall score in predicting the need for endoscopic therapy in patients with upper GI hemorrhage. Gastrointest Endosc 2010;71:1134-40.
5. Stanley AJ, Ashley D, Dalton HR, et al. Outpatient management of patients with low-risk upper-gastrointestinal haemorrhage: multicentre validation and prospective evaluation. Lancet 2009;373:42-7.
6. Lai KC, Hui WM, Wong BC, et al. A retrospective and prospective study on the safety of discharging selected patients with duodenal ulcer bleeding on the same day as endoscopy. Gastrointest Endosc 1997;45:26-30. (Pubitemid 27058374)
7. Hsu PI, Lai KH, Lin XZ, et al. When to discharge patients with bleeding peptic ulcers: a prospective study of residual risk of rebleeding. Gastrointest Endosc 1996;44:382-7.
8. Cipoletta L, Bianco MA, Rotondano G, et al. Outpatient management for low-risk non-variceal upper GI bleeding: a randomized controlled trial. Gastrointest Endosc 2002;55:1-5. (Pubitemid 41122915)
9. Brullet E, Campo R, Calvet X, et al. A randomized study of the safety of outpatient care patients with bleeding peptic ulcer treated by endoscopic injection. Gastrointest Endosc 2004;60:15-21. (Pubitemid 38842424)
10. Sung JJ, Tsoi KK, Ma TK, et al. Causes of mortality in patients with peptic ulcer bleeding: a prospective cohort study of 10,428 cases. Am J Gastroenterol 2010;105:84-9.
11. Lau JY, Leung WK, Wu JC, et al. Omeprazole before endoscopy in patients with gastrointestinal bleeding. N Engl J Med 2007;356:1631-40. (Pubitemid 46631672)
12. Sreedharan A, Martin J, Leontiadis G, et al. Does proton pump inhibitor (PPI) treatment initiated before endoscopy work in unselected upper gastrointestinal bleeding? A Cochrane systematic review update. Cochrane Database Syst Rev 2010;(7):CD005415.
13. Tsoi KK, Lau JY, Sung JJ. Cost-effectiveness analysis of high-dose omeprazole infusion before endoscopy for patients with upper-GI bleeding. Gastrointest Endosc 2008;67:1056-63.
14. Lin H, Wang K, Perng CL, et al. Early or delayed endoscopy for patients with peptic ulcer bleeding: a prospective randomized study. J Clin Gastroenterol 1996;22:267-71. (Pubitemid 26001151)
15. Lee JG, Turnipseed S, Romano PS, et al. Endoscopy-based triage significantly reduces hospitalization rate and costs of treating upper GI bleeding: a randomized controlled trial. Gastrointest Endosc 1999;50:755-61.
16. Bjorkman DJ, Zaman A, Fennerty MB, et al. Urgent vs elective endoscopy for acute non-variceal upper GI bleeding: an effectiveness study. Gastrointest Endosc 2004;60:1-8. (Pubitemid 38833691)
17. Tsoi KK, Ma TK, Sung JJ. Endoscopy for upper gastrointestinal bleeding: how urgent is it? Nat Rev Gastroenterol Hepatol 2009;6:463-9.
18. Shaheen AA, Kaplan GG, Myers RP. Weekend versus weekday admission and mortality from gastrointestinal hemorrhage caused by peptic ulcer disease. Clin Gastroenterol Hepatol 2009;7:303-10.
19. Dorn SD, Shah ND, Berg BP, et al. Effect of weekend admission on gastrointestinal outcomes. Dig Dis Sci 2010;55:1658-66.
20. Ananthakrishnan AN, McGinley EL, Saeian K. Outcomes of weekend admissions for upper gastrointestinal hemorrhage: a nationwide analysis. Clin Gastroenterol Hepatol 2009;7:296-302.
21. Tsoi KK, Pang SH, Chiu PW, et al. The risk of ulcer-related death in relation to hospital admission on public holidays: a cohort study on 10,428 cases of upper gastrointestinal bleeding in Hong Kong. Gastrointest Endosc 2010;71:AB141.
22. Sung JJ, Chan FK, Lau JY, et al. The effect of endoscopic therapy in patients receiving omeprazole for bleeding ulcers with nonbleeding visible vessels or adherent clots: a randomized comparison. Ann Intern Med 2003;139:237-43.
23. Lau JY, Chung SC, Leung JW, et al. The evolution of stigmata of hemorrhage in bleeding peptic ulcers: a sequential endoscopic study. Endoscopy 1998;30:513-18. (Pubitemid 28409967)
24. Sung JJ, Barkun A, Kuipers EJ, et al; Peptic Ulcer Bleed Study Group. Intravenous esomeprazole for prevention of recurrent peptic ulcer bleeding: a randomized trial. Ann Intern Med 2009;150:455-64.
25. Jensen DM, Ahlbom H, Eklund S, et al. Rebleeding risk for oozing peptic ulcer bleeding (PUB) in a large international study - a reassessment based upon a multivariate analysis. Gastrointest Endosc 2010;71:AB117.
26. Kahi CJ, Jensen DM, Sung JJ, et al. Endoscopic therapy versus medical therapy for bleeding peptic ulcer with adherent clot: a meta-analysis. Gastroenterology 2005;129:855-62. (Pubitemid 41242678)
27. Laine L. Systematic review of endoscopic therapy for ulcers with clots: can a meta-analysis be misleading. Gastroenterology 2005;129:2127.
28. Saeed ZA, Cole RA, Ramirez FC, et al. Endoscopic retreatment after successful initial hemostasis prevents ulcer rebleeding: a prospective randomized trial. Endoscopy 1996;28:288-94. (Pubitemid 26168161)
29. Tsoi KK, Chiu PW, Sung JJ. Endoscopy for upper gastrointestinal bleeding: is routine second look necessary? Nat Rev Gastroenterol Hepatol 2009;6:717-22.
30. Chiu P, Choi C, Kwong K-H, et al. The effect of scheduled second endoscopy against intravenous high dose omeprazole infusion as an adjunct to therapeutic endoscopy in prevention of peptic ulcer rebleeding - a prospective randomized study. Gastroenterology 2006;130:A121.
31. Tsoi KK, Chan HC, Chiu PW, et al. Second-look endoscopy with thermal coagulation or injections for peptic ulcer bleeding: a meta-analysis. J Gastroenterol Hepatol 2010;25:8-13.
32. Leontiadis GI, Sharma VK, Howden CW. Proton pump inhibitor treatment for acute peptic ulcer bleeding. Cochrane Database Syst Rev 2006;(1):CD002094.
33. Leontiadis G, Martin J, Sharma V, et al. Proton pump inhibitor (PPI) treatment for peptic ulcer (PU) bleeding: an updated Cochrane metaanalysis of randomized controlled trials (RCTs). Gastroenterology 2009;136:A134.
34. Barkun AN, Herba K, Adam V, et al. High-dose intravenous proton pump inhibition following endoscopic therapy in the acute management of patients with bleeding peptic ulcers in the USA and Canada: a cost-effectiveness analysis. Aliment Pharmacol Ther 2004;19:591-600. (Pubitemid 38387186)
35. Lee KK, You JH, Wong IC, et al. Cost-effectiveness analysis of high-dose omeprazole infusion as adjuvant therapy to endoscopic treatment of bleeding peptic ulcer. Gastrointest Endosc 2003;57:160-4. (Pubitemid 36236751)
36. Khuroo MS, Yattoo GN, Javid G, et al. A comparison of omeprazole and placebo for bleeding peptic ulcer. N Engl J Med 1997;336:1054-8. (Pubitemid 27163857)
37. Jang J, Dong S, Jung J, et al. High-dose oral proton pump inhibitor is as effective as intravenous administration in the aspect of increasing pH and reducing rebleeding after endoscopic treatment of bleeding peptic ulcers. Gastroenterology 2006;103:A467.
38. Bajaj JS, Dua KS, Hanson K, et al. Prospective, randomized trial comparing effect of oral versus intravenous pantoprazole on rebleeding after nonvariceal upper gastrointestinal bleeding: a pilot study. Dig Dis Sci 2007;52:2190-4. (Pubitemid 47246493)
39. Javid G, Masoodi I, Zargar SA, et al. Omeprazole as adjuvant therapy to endoscopic combination therapy for treating bleeding peptic ulcer. Am J Med 2001;111:280-4. (Pubitemid 32885623)
40. Kaviani MJ, Hashemi MR, Kazemifar AR, et al. Effect of oral omeprazole in reducing re-bleeding in bleeding peptic ulcers: a prospective, double-blind, randomized, clinical trial. Aliment Pharmacol Ther 2003;17:211-16. (Pubitemid 36174251)
41. Laine L, McQuaid KR. Endoscopic therapy for bleeding ulcers: an evidence-based approach based on meta-analysis of randomized controlled trial. Clin Gastroenterol Hepatol 2009;7:33-47.
42. Wang CH, Ma MHM, Chou HC, et al. High-dose vs non-high-dose proton pump inhibitors after endoscopic treatment in patients with bleeding peptic ulcer: a systematic review and meta-analysis of randomized controlled trials. Arch Intern Med 2010;170:751-8.
43. Calvet X, Barkun A, Bardou M, et al. High-dose vs non-high-dose PPIs after endoscopic treatment in patients with bleeding peptic ulcer: current evidence is insufficient to claim equivalence. Arch Intern Med 2010;170:1698-9 author reply 1700.
44. Choi KD, Kim N, Jang IJ, et al. Optimal dose of intravenous pantoprazole in patients with peptic ulcer bleeding requiring endoscopic hemostasis in Korea. J Gastroenterol Hepatol 2009;24:1617-24.
45. Lau JY, Sung JJ, Lam YH, et al. Endoscopic retreatment compared with surgery in patients with recurrent bleeding after initial endoscopic control of bleeding ulcers. N Engl J Med 1999;340:751-6. (Pubitemid 29114293)
46. Loffroy R, Guiu B, D'Athis P, et al. Arterial embolotherapy for endoscopically unmanageable acute gastroduodenal hemorrhage: predictors of early rebleeding. Clin Gastroenterol Hepatol 2009;7:515-23.
47. Ripoll C, Banares R, Beceiro I, et al. Comparison of transcatheter arterial embolization and surgery for treatment of bleeding peptic ulcer after endoscopic treatment failure. J Vasc Interv Radiol 2004;15:447-50. (Pubitemid 38590867)
48. Wong TC, Chiu PW, Wong KT, et al. A comparison of transcatheter arterial embolisation to surgery after failed endoscopic hemostasis to bleeding peptic ulcers. Gastrointest Endosc 2010;71:AB113-14.
49. Chan FK, Hung LC, Suen BY, et al. Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis. N Engl J Med 2002;347:2104-10. (Pubitemid 36015122)
50. Chan FK, Wong VW, Suen BY, et al. Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial. Lancet 2007;369:1621-6. (Pubitemid 46710125)
51. Lai KC, Chu KM, Hui WM, et al. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications. Am J Med 2005;118:1271-8.
52. Spertus JA, Kettelkamp R, Vance C, et al. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation 2006;113:2803-9. (Pubitemid 44305292)
53. Sung JJ, Lau JY, Ching JY, et al. Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial. Ann Intern Med 2010;152:1-9.
54. CAPRIE Steering Committee. A randomized, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events. Lancet 1996;348:1329-39.
55. Chan FK, Ching JY, Hung LC, et al. Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding. N Engl J Med 2005;352:238-44. (Pubitemid 40110812)
56. Lai KC, Chu KM, Hui WM, et al. Esomeprazole with aspirin versus clopidogrel for prevention of recurrent gastrointestinal ulcer complications. Clin Gastroenterol Hepatol 2006;4:860-5.
57. Weil J, Colin-Jones D, Langman M, et al. Prophylactic aspirin and risk of peptic ulcer bleeding. BMJ 1995;310:827-30.
58. Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001;358:527-33. (Pubitemid 32772726)
59. Yun KH, Rhee SJ, Park HY, et al. Effect of omeprazole on the antiplatelet activity of clopidogrel. Int Heart J 2010;51:13-16.
60. Sibbing D, Morath T, Stegherr J, et al. Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel. Thromb Haemost 2009;101:714-19.
61. Neubauer H, Engelhardt A, Kruger JC, et al. Pantoprazole does not influence the antiplatelet activity of clopidogrel - a whole blood aggregometry study after coronary stenting. J Cardiovasc Pharmacol 2010;56:91-7.
62. Gaglia MA Jr, Torguson R, Hanna N, et al. Relation of proton pump inhibitor use after percutaneous conronary intervention with drug-eluting stents to outcomes. Am J Cardiol 2010;105:833-8.
63. Juurlink DN, Gomes T, Ko DT, et al. A population-based study of the drug interaction between proton pump inhibitors and clopidogrel. CMAJ 2009;180:713-18.
64. Ho PM, Maddox TM, Wang L, et al. Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. JAMA 2009;301:937-44.
65. Huang CC, Chen YC, Leu HB, et al. Risk of adverse outcomes in Taiwan associated with concomitant use of clopidogrel and proton pump inhibitors in patients who received percutaneous coronary intervention. Am J Cardiol 2010;105:1705-9.
66. O'Donoghue ML, Braunwald E, Antman EM, et al. Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials. Lancet 2009;374:989-97.
67. Ray WA, Murray KT, Griffin MR, et al. Outcomes with concurrent use of clopidogrel and proton-pump inhibitors: a cohort study. Ann Intern Med 2010;152:337-45.
68. Kwok CS, Loke YK. Meta-analysis: the effects of proton pump inhibitors on cardiovascular events and mortality in patients receiving clopidogrel. Aliment Pharmacol Ther 2010;31:810-23.
69. de Aquino Lima JP, Brophy JM. Conflicting evidence: what's a clinician to do? Ann Intern Med 2010;153:413-15.
70. Bhatt DL, Cryer BL, Contant CF, et al. Clopidogrel with or without omeprazole in coronary artery disease. N Engl J Med 2010;363:1909-17.